Asset Management bought shares of Rigel Pharmaceuticals, Inc., and Citigroup issued a buy rating on the company.
2 reports, 1 independent
Updated Aug 27
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Asset Management bought shares of Rigel Pharmaceuticals, Inc., and Citigroup issued a buy rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- Asset Management
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup restated a buy rating on the stock of Stora Enso.
- Citigroup raised shares to a buy rating for Fisher & Paykel Healthcare.
- Citigroup reissued a buy rating on Paylocity shares.
- MarketBeat reported consensus ratings, Geode Capital Management raised its stake, Citigroup reissued a buy rating, and Benchmark restated a speculative buy rating regarding Intensity Therapeutics.
- Benchmark downgraded its shares from buy to hold, while Morgan Stanley and Citigroup issued rating updates.